glp-1/gip dual agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Dual GIP–GLP1-Receptor Agonists In The

Market Expansion & Competition Rival GLP-1 pills are in late-stage development, including Eli Lillys orforglipron , which could be approved in 2026

doi: 10.1371/journal.pone.0135233

There are clinical trials evaluating if these GLP-1 and multi-agonists can address neurodegeneration, addiction, inflammation, and beyond

Semaglutide (Ozempic, Wegovy, Rybelsus) Semaglutide comes in three brand names with different uses and delivery methods: is Ozempic approved for improving blood sugar control in adults with type 2 diabetes, and for reducing the risk for heart problems and end-stage kidney disease in those with diabetes

Will my GLP-1 side effects go away

Epidemiological data on suicide reveals that the 12-month prevalence of suicidal ideation is greater in females than males whereas the prevalence of suicide attempts is comparable for females and males [Reference Borges, Nock, Haro Abad, Hwang, Sampson and Alonso36]